Clinical pharmacy became a part of the modern medical lexicon in the 1960s, with pharmacy schools and pharmacists making an effort to become more patient-centered. From the role of the pharmacist in patient service, to the influence of technology in pharmacy practice, to the way our patients view our profession, how have things changed for the better? William Zellmer, former deputy executive vice president for the American Society of Health-System Pharmacists, surveys the past 40 years in clinical pharmacy with host Dr. Charles Turck. Where can we improve upon the lessons of the last several decades?
The Evolution of Clinical Pharmacy Practice
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Clinical pharmacy became a part of the modern medical lexicon in the 1960s, with pharmacy schools and pharmacists making an effort to become more patient-centered. From the role of the pharmacist in patient service, to the influence of technology in pharmacy practice, to the way our patients view our profession, how have things changed for the better? William Zellmer, former deputy executive vice president for the American Society of Health-System Pharmacists, surveys the past 40 years in clinical pharmacy with host Dr. Charles Turck. Where can we improve upon the lessons of the last several decades?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
1.75 credits
<p>Clinical Considerations for the Diagnosis of Endometriosis</p>
MinuteCE®
Don’t Wait to Escalate—Getting Aggressive in PH Management
1.00 credits
<p>Don’t Wait to Escalate—Getting Aggressive in PH Management</p>
MinuteCE®
Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type</span> </p>
MinuteCE®
Biomarkers of the Storm: Decoding IRI’s Signature
0.50 credits
<p>Biomarkers of the Storm: Decoding IRI’s Signature</p>
MinuteCE®
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
1.00 credits
<p>Application of guidelines-recommended broad molecular profiling to patients with NSCLC</p>
Project Oncology®
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
<p>Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols</p>
MinuteCE®
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
1.00 credits
<p>Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?